Literature DB >> 21591024

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Amandine I Garcia1, David G Cox, Laure Barjhoux, Carole Verny-Pierre, Daniel Barnes, Antonis C Antoniou, Dominique Stoppa-Lyonnet, Olga M Sinilnikova, Sylvie Mazoyer.   

Abstract

The rs2910164:G>C SNP is located in the gene for miR-146a, a microRNA that binds the 3' UTR of the BRCA1 transcript. Preliminary data based on the analysis of a small number of cases suggested that this single nucleotide polymorphism (SNP) might be associated with the age of onset of familial breast and ovarian cancer. This effect was not confirmed on a large series of familial breast cancer cases negative for a BRCA1 or BRCA2 mutation. We show here a lack of association of the rs2910164:G>C SNP with breast cancer risk in a series of 1,166 BRCA1 and 560 BRCA2 mutation carriers. In conclusion, the polymorphism in the miR-146a gene is unlikely to be of substantial significance regarding breast cancer risk.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21591024     DOI: 10.1002/humu.21539

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  22 in total

Review 1.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

2.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene.

Authors:  S E Löfgren; J Frostegård; L Truedsson; B A Pons-Estel; S D'Alfonso; T Witte; B R Lauwerys; E Endreffy; L Kovács; C Vasconcelos; B Martins da Silva; S V Kozyrev; M E Alarcón-Riquelme
Journal:  Genes Immun       Date:  2012-01-05       Impact factor: 2.676

3.  Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis.

Authors:  Zhihua Yin; Lei Yan; Zhigang Cui; Xuelian Li; Yangwu Ren; Baosen Zhou
Journal:  Mol Biol Rep       Date:  2013-01-06       Impact factor: 2.316

Review 4.  BRCA1 and microRNAs: emerging networks and potential therapeutic targets.

Authors:  Suhwan Chang; Shyam K Sharan
Journal:  Mol Cells       Date:  2012-07-24       Impact factor: 5.034

5.  Association of microRNA-146a and its target gene IRAK1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis.

Authors:  Sushma Singh; Geeta Rai; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2014-04-10       Impact factor: 2.631

6.  Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer.

Authors:  Renata Hezova; Alena Kovarikova; Julie Bienertova-Vasku; Milana Sachlova; Martina Redova; Anna Vasku; Marek Svoboda; Lenka Radova; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

7.  Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer.

Authors:  Hanan S Elsarraj; Shane R Stecklein; Kelli Valdez; Fariba Behbod
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-19       Impact factor: 2.673

8.  Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis.

Authors:  Qiao-Hui Chen; Qing-Bing Wang; Bei Zhang
Journal:  Tumour Biol       Date:  2013-08-29

9.  Genetic variants in microRNAs and breast cancer risk in African American and European American women.

Authors:  Song Yao; Kelly Graham; Jie Shen; Lara E Sucheston Campbell; Prashant Singh; Gary Zirpoli; Michelle Roberts; Gregory Ciupak; Warren Davis; Helena Hwang; Thaer Khoury; Dana H Bovbjerg; Lina Jandorf; Karen S Pawlish; Elisa V Bandera; Song Liu; Christine B Ambrosone; Hua Zhao
Journal:  Breast Cancer Res Treat       Date:  2013-09-24       Impact factor: 4.872

Review 10.  The role of microRNAs in cancer susceptibility.

Authors:  Rodolfo Iuliano; Marco Flavio Michele Vismara; Vincenzo Dattilo; Francesco Trapasso; Francesco Baudi; Nicola Perrotti
Journal:  Biomed Res Int       Date:  2013-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.